In short. The skin-quality, under-eye and hair claims graded separately, with the size, length and funding of the studies behind each one stated alongside the finding.
Key points
- A finding repeated in several small studies is stronger than a finding reported once.
- It is not the same as a finding in a large trial with long follow-up.
- The size of the study is not a technicality; it is the difference between a signal and a result.
The claims made for polynucleotide injectables are three, and they are not equally supported. Taken separately, each has a different amount of evidence behind it, and the honest summary is that all three rest on small studies and that the hair claim rests on the smallest of the three. None of them has the kind of literature behind it that a reader would expect for a treatment in wide use.
Skin quality
This is the best studied of the three. Several small randomised studies have reported improvements in measured hydration, elasticity and roughness after a course of treatment, usually assessed with instruments and sometimes with photographs. The limits are consistent across them: the groups are small, follow-up is measured in months rather than years, the work comes from a small number of centres, and a substantial share of it is supported by the companies that sell the material. Small and consistent is still small.
Under-eye appearance
Studies of the thin skin under the eye report changes in dark circles and in skin quality in some participants, with results that vary between studies. A dark circle has several possible causes: pigment in the skin, visible vessels beneath it, and a shadow cast by a fat pad. A treatment that changes skin quality does not address the structural cause, and a study reporting an average change in a small group cannot say which cause was present in which participant.
Small and consistent is still small
A finding repeated in several small studies is stronger than a finding reported once. It is not the same as a finding in a large trial with long follow-up. The size of the study is not a technicality; it is the difference between a signal and a result.
Hair
The hair claim is the earliest and the thinnest. Small trials in pattern hair thinning have reported changes in hair counts and in measured hair diameter over short periods, in groups small enough that a few participants moving in either direction changes the average. Hair growth is also unusually responsive to expectation, which makes an uncontrolled result very hard to read: a participant who expects to see a change is more likely to report one, and an assessor who knows what was injected is more likely to record one. This is a signal worth following, and it is not yet a finding.
What to ask about any of these studies
- How many people were treated, and for how long were they followed afterwards?
- Was there a comparison group, and were the assessors kept unaware of who received what?
- Who funded the work, and was it replicated independently of the company selling the product?
A reader who asks those three questions will end up with a more accurate picture than any summary can give them, and the answers will usually be shorter and more cautious than the page that prompted the question.
Frequently asked questions
Which polynucleotide claim has the most evidence behind it?
Skin quality. Several small randomised studies have reported changes in measured hydration, elasticity and roughness after a course. The limits are consistent across them: small groups, follow-up measured in months, work from a small number of centres, and a substantial share of it supported by the companies selling the material.
Do polynucleotides work for dark circles under the eyes?
Small studies report changes in some participants, with results that vary between studies. Under-eye darkness has several possible causes, including pigment, visible vessels and a shadow cast by a fat pad, and a treatment that changes skin quality does not address the structural ones. Which cause is present in a particular person matters more than the group average.
Is the evidence for hair thinning stronger or weaker?
Weaker. Small trials in pattern hair thinning have reported changes in hair counts and measured diameter over short periods, in groups small enough that a few participants moving either way changes the average. Hair growth is also unusually responsive to expectation, which makes an uncontrolled result very hard to read.
Risks & Limitations
- The published studies behind this product class are small, short and concentrated in a few centres, and a substantial share are supported by the companies selling the material.
- Long-term behaviour of the material is unmeasured, which is not the same as established and not the same as disproven.
- The material is marine-derived, so an allergy question exists and no straightforward test predicts a reaction.
- A material intended to provoke a tissue response can produce nodules or a granuloma, which are harder to manage than an unwanted filler that can be dissolved.
- A device registration records the safety and performance of a material and is not a finding that the treatment works; an injectable into the face also carries the rare risk of a vascular event.
When to Seek Care
- A firm lump, nodule or area of swelling appearing weeks or months after an injection — have it assessed by a clinician.
- Skin that turns white, dusky or painful during or shortly after an injection, or any change in vision — seek care immediately.
- Spreading redness, warmth or fever, or pain that is worsening rather than settling.
- Contact the service that holds your records, or the hospital’s outpatient channels, rather than relying on a website.
References & Further Reading
- European Medicines Agency (EMA) and national regulators — classification of injectable products and published assessment reports
- U.S. Food and Drug Administration (FDA) — device and drug classification, and approved labelling
- National Medical Products Administration (NMPA, China) — registration of medical devices and medicines
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.